Skip to main content

Table 3 Base case cost-effectiveness analysis

From: The optimal diagnostic strategies for patient with coronary artery diseases and stable chest pain syndrome: a cost-effectiveness analysis

 

Cost ($)

Incremental cost

Effectiveness

Incremental effectiveness

ICER

ACER

Total strategies

 Strategy 5

48.183

-

0.003

-

-

16,061.091

 Strategy 4

104.076

55.893

0.043

0.04

1397.342

2420.394

 Strategy 7

108.378

60.195

0.137

0.342

176.009

791.084

 Strategy 6

166.415

118.232

2.572

2.568

46.040

64.702

 Strategy 8

255.088

206.905

0.078

0.074

2796.019

3270.367

 Strategy 1

364.571

316.388

1.896

1.893

167.135

192.284

 Strategy 3

561.280

513.097

14.488

14.484

35.425

38.741

 Strategy 2

1475.128

1426.945

93.899

93.895

15.197

15.709

 Strategy 9

3450.017

3401.834

36.020

36.017

94.450

95.780

Acute patient strategies

 Strategy 2

364.571

-

93.899

-

-

3.882

 Strategy 1

1475.128

− 1110.557

1.896

-92.002

12.071

778.021

Chronic patient strategies

 Strategy 5

48.18327345

-

0.003

-

-

16,061.09115

 Strategy 4

104.0769569

55.89368341

0.043

0.04

1397.342085

2420.394346

 Strategy 7

108.3785836

60.19531012

0.137

0.342

176.0096787

791.0845516

 Strategy 6

166.4153344

118.232061

2.572

2.568

46.04052219

64.70269613

 Strategy 3

561.2803499

513.0970764

14.488

14.484

35.42509503

38.74105121